Qube Research & Technologies (QRT)
SAGE

Qube Research & Technologies (QRT)’s Sage Therapeutics SAGE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,082,003
Closed -$9.87M – 3900
2025
Q2 		$9.87M Buy
+1,082,003
New +$7.96M 0.01% 1296
2024
Q4 		– Sell
-165,190
Closed -$1.19M – 3772
2024
Q3 		$1.19M Sell
165,190
-68,831
-29% -$630K ﹤0.01% 1967
2024
Q2 		$2.54M Buy
234,021
+127,903
+121% +$1.64M ﹤0.01% 1526
2024
Q1 		$1.99M Buy
106,118
+58,694
+124% +$1.35M ﹤0.01% 1759
2023
Q4 		$1.03M Buy
+47,424
New +$940K ﹤0.01% 1912
2023
Q3 		– Sell
-77,924
Closed -$3.66M – 4295
2023
Q2 		$3.66M Buy
+77,924
New +$3.88M 0.01% 801
2023
Q1 		– Sell
-7,953
Closed -$303K – 2963
2022
Q4 		$303K Buy
+7,953
New +$304K ﹤0.01% 1645
2021
Q4 		– Sell
-28,697
Closed -$1.27M – 2907
2021
Q3 		$1.27M Buy
28,697
+14,208
+98% +$652K 0.02% 820
2021
Q2 		$823K Sell
14,489
-49,418
-77% -$3.49M 0.01% 1029
2021
Q1 		$4.78M Buy
63,907
+48,432
+313% +$3.97M 0.08% 347
2020
Q4 		$1.34M Buy
+15,475
New +$1.14M 0.02% 771
2020
Q2 		– Sell
-26,738
Closed -$768K – 1948
2020
Q1 		$768K Buy
+26,738
New +$1.55M 0.03% 453

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SAGE Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 1,082,003 shares — an estimated $9.87M sold.

Qube Research & Technologies (QRT) first reported a position in SAGE in Q1 2020 and held it in 12 quarters. The position peaked at $9.87M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,082,003 Sage Therapeutics shares in Q3 2025, an estimated $9.87M.
  • Qube Research & Technologies (QRT) first reported a position in Sage Therapeutics in Q1 2020 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s Sage Therapeutics position peaked at $9.87M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.